Susquehanna International Group
SGMO

Susquehanna International Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Susquehanna International Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Buy
603,100
+132,700
+28% +$52.8K ﹤0.01% 11996
2025
Q4 		$198K Sell
470,400
-13,200
-3% -$7K ﹤0.01% 10892
2025
Q3 		$324K Sell
483,600
-134,500
-22% -$72.5K ﹤0.01% 9936
2025
Q2 		$334K Sell
618,100
-215,800
-26% -$128K ﹤0.01% 10094
2025
Q1 		$550K Buy
833,900
+1,700
+0.2% +$1.8K ﹤0.01% 8690
2024
Q4 		$849K Buy
832,200
+356,900
+75% +$652K ﹤0.01% 7376
2024
Q3 		$414K Buy
+475,300
New +$348K ﹤0.01% 8924
2023
Q2 		– Sell
-32,500
Closed -$57.2K – 13024
2023
Q1 		$57.2K Sell
32,500
-127,900
-80% -$365K ﹤0.01% 11636
2022
Q4 		$504K Sell
160,400
-47,800
-23% -$186K ﹤0.01% 7860
2022
Q3 		$1.02M Sell
208,200
-102,700
-33% -$528K ﹤0.01% 6587
2022
Q2 		$1.29M Sell
310,900
-17,700
-5% -$76.5K ﹤0.01% 5907
2022
Q1 		$1.91M Buy
328,600
+32,700
+11% +$194K ﹤0.01% 5583
2021
Q4 		$2.22M Sell
295,900
-113,400
-28% -$985K ﹤0.01% 5271
2021
Q3 		$3.69M Buy
409,300
+58,100
+17% +$574K ﹤0.01% 4527
2021
Q2 		$4.2M Buy
351,200
+24,500
+7% +$277K ﹤0.01% 4347
2021
Q1 		$4.09M Sell
326,700
-230,200
-41% -$3.1M ﹤0.01% 4308
2020
Q4 		$8.69M Sell
556,900
-45,800
-8% -$537K ﹤0.01% 2664
2020
Q3 		$5.7M Buy
602,700
+127,100
+27% +$1.37M ﹤0.01% 2890
2020
Q2 		$4.26M Buy
475,600
+131,600
+38% +$1.22M ﹤0.01% 3235
2020
Q1 		$2.19M Buy
344,000
+92,600
+37% +$687K ﹤0.01% 3808
2019
Q4 		$2.1M Sell
251,400
-451,400
-64% -$4.15M ﹤0.01% 4244
2019
Q3 		$6.36M Sell
702,800
-20,600
-3% -$231K ﹤0.01% 2431
2019
Q2 		$7.79M Sell
723,400
-456,700
-39% -$4.86M ﹤0.01% 2165
2019
Q1 		$11.3M Buy
1,180,100
+554,300
+89% +$5.66M ﹤0.01% 1629
2018
Q4 		$7.18M Sell
625,800
-279,200
-31% -$3.47M ﹤0.01% 1901
2018
Q3 		$15.3M Buy
905,000
+190,000
+27% +$2.89M 0.01% 1533
2018
Q2 		$10.2M Buy
715,000
+298,200
+72% +$4.95M ﹤0.01% 1925
2018
Q1 		$7.92M Sell
416,800
-68,100
-14% -$1.46M ﹤0.01% 2022
2017
Q4 		$7.95M Buy
484,900
+222,600
+85% +$3.31M ﹤0.01% 2039
2017
Q3 		$3.94M Sell
262,300
-35,400
-12% -$391K ﹤0.01% 2830
2017
Q2 		$2.62M Buy
297,700
+114,700
+63% +$736K ﹤0.01% 3394
2017
Q1 		$952K Buy
183,000
+86,500
+90% +$347K ﹤0.01% 5227
2016
Q4 		$294K Sell
96,500
-3,700
-4% -$13.5K ﹤0.01% 8012
2016
Q3 		$464K Sell
100,200
-51,700
-34% -$263K ﹤0.01% 6189
2016
Q2 		$880K Sell
151,900
-16,600
-10% -$106K ﹤0.01% 5109
2016
Q1 		$1.02M Sell
168,500
-1,011,200
-86% -$6.07M ﹤0.01% 5046
2015
Q4 		$10.8M Sell
1,179,700
-71,900
-6% -$554K 0.01% 1677
2015
Q3 		$7.06M Sell
1,251,600
-276,700
-18% -$2.28M ﹤0.01% 2234
2015
Q2 		$16.9M Buy
1,528,300
+23,500
+2% +$303K 0.01% 1468
2015
Q1 		$23.6M Buy
1,504,800
+74,500
+5% +$1.15M 0.01% 1115
2014
Q4 		$21.8M Sell
1,430,300
-290,400
-17% -$3.53M 0.01% 1289
2014
Q3 		$18.6M Buy
1,720,700
+75,000
+5% +$980K 0.01% 1488
2014
Q2 		$25.1M Sell
1,645,700
-208,800
-11% -$3M 0.01% 1194
2014
Q1 		$33.5M Buy
1,854,500
+1,373,000
+285% +$26.5M 0.02% 873
2013
Q4 		$6.69M Sell
481,500
-41,000
-8% -$472K ﹤0.01% 2537
2013
Q3 		$5.48M Sell
522,500
-50,000
-9% -$497K ﹤0.01% 2597
2013
Q2 		$4.47M Buy
+572,500
New +$4.99M ﹤0.01% 2763

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's SGMO Position: Q1 2026 in Review

Susquehanna International Group reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 21% in Q1 2026, selling an estimated $179K and leaving 1,687,463 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #10115.

Susquehanna International Group first reported a position in SGMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.01M in Q3 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Susquehanna International Group held 1,687,463 shares of SANGAMO THERAPEUTICS INC worth $417K as of Q1 2026.
  • Susquehanna International Group sold 449,657 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $179K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10115 holding.
  • Susquehanna International Group first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 52 quarters since.
  • Susquehanna International Group's SANGAMO THERAPEUTICS INC position peaked at $9.01M in Q3 2018.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.